1 Min Read
Jan 9 (Reuters) - Oryzon Genomics SA :
* Enrolls first patient for phase I clinical trial for RG6016 for small cell lung cancer for study carried out by Roche
Source text: bit.ly/2iV8Mk8
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.